A tRNA modifier at work

July 11, 2019

sbcf_symbol_colour

Structural Biology Core Facility supported once again excellent research! Our frequent users publish in Science Advances. 

All living cells employ ribosomes and transfer RNA (tRNA) molecules to decode mRNA sequences and translate the codon-triplet-encoded information into correctly assembled and functional proteins. Furthermore, it is crucial for the cells to produce these proteins at the right speed to avoid protein misfolding and intracellular aggregates. The modifications of tRNAs with small chemical groups by specialized enzymes is one way to tune the production speed at the correct pace.

A team of scientists from the Małopolska Centre of Biotechnology (MCB) at the Jagiellonian University in Krakow, the Martin Luther University Halle-Wittenberg and the European Molecular Biology Laboratory (EMBL) have managed to catch a crucial cellular modification machinery directly at work. In detail, they have used cryo-electron microscopy (cryo-EM) to determine the structures of a large protein complex, called Elongator, in the presence and absence of its natural substrate tRNA. Their results were published this week in Science Advances (you can read the publication here).

The results are extremely valuable for the whole research community interested in protein synthesis, as they allow for a more complete understanding of one of the key mechanisms in ribosome-mediated protein synthesis where tRNA plays a central role as adaptor molecule. The highly conserved Elongator complex is responsible for the introduction of specific and very complex chemical modification in the anticodon of the tRNA molecule. It was previously shown, that the lack of this modification caused by the dysfunction of Elongator leads to abnormal ribosome dynamics, degenerated protein synthesis, protein misfolding and intracellular aggregates. “After 10 years of research on this large cellular machine, we finally start to have a clearer picture of the complicated interplay between the different Elongator subunits and the bound substrate tRNA that permit the modification reaction” explain Christoph W Müller and Jan Kosinski located at EMBL Heidelberg and EMBL Hamburg, respectively. Strikingly, mutations in any of the six subunits of Elongator are associated with the onset of severe human diseases, including familial dysautonomia, obesity, bronchial asthma, intellectual disability, ventricular hypertrophy, Rolandic Epilepsy and cancer. “Our structural work tells us how the tRNA is specifically positioned in the active site of the complex, but also allows a structure-based design of specific drug molecules that might cure Elongator related diseases in the future” says Sebastian Glatt, Max Planck Research Group Leader at MCB and last author of the study.

Researchers obtained high-resolution structures using the cryo-EM method, which was distinct with the Nobel Prize for Chemistry in 2017 and will soon be also available in Poland. A state-of-the-art microscope with the latest direct electron detectors is already installed at the SOLARIS National Synchrotron Radiation Center  of the Jagiellonian University and is currently undergoing commissioning. For application details for time at the microscope please go to the Solaris website. 

The research in Krakow was financed from an OPUS grant from the National Science Centre and the Homing and Team Tech Core Facility programs from the Foundation for Polish Science (FNP) with the support of the Structural Biology Core Facility at MCB.

elongator at work
Cryo-EM structure of Elp123 bound to tRNA with co-factors SAM and acetyl-COA participating in the modification of U34 tRNA

ProtXRD Workshops

NEWS ProtXRD workshop on data collection and structure solving in macromolecular X-ray diffraction July 18th, 2019 On 12th – 16th of July in Krakow Institute of Catalysis and Surface Chemistry…